Ocular Oncology and Pathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.2 | Q4 | 23.5% | 0.516 | Q2 | 62.1% |
| 2024 | 1.3 | Q3 | 34.7% | 0.423 | Q2 | 56.7% |
| 2023 | 0.9 | Q4 | 23.5% | 0.426 | Q2 | 59.7% |
| 2022 | 1.0 | 23.8% | 0.360 | Q2 | 56.2% | |
| 2021 | — | 38.3% | 0.432 | Q2 | 62.6% | |
| 2020 | — | — | 0.444 | Q2 | 62.7% | |
| 2019 | — | — | 0.471 | Q2 | 65.7% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2296-4657
ISSN
2296-4681
region
Western Europe
coverage
2014-2026